🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

With a Pneumothorax rate of 3.3% in the navigational bronchoscopy group & 28.3% in the transthoracic biopsy group, Navigational bronch might be new standard of care. The diagnostic accuracy of #navigationalbronchoscopy was noninferior to that of transthoracic needle biopsy

This Guide to Statistics and Methods describes the state-of-the-art and best practices for using and reporting these powerful methods while avoiding their pitfalls. ja.ma/3Z01Ghl

Living on the edge: Role of adjuvant therapy after resection of primary lung cancer within 2 millimeters of a T-stage cutoff. Log in to #JTCVS to read this recently published study from Keck School of Medicine of USC: doi.org/10.1016/j.jtcv… Brooks Udelsman Gavitt Woodard

What are the long-term outcomes from #DCD #lungtransplant? This meta-analysis demonstrates better survival when compared to DBD lungs further supporting that they are an excellent source of donor lungs. 🫁 @Ssaddoughi @mayocliniccvs Mayo Clinic Transplant 🔗: jhltonline.org/article/S1053-…

Increased risk of 13 different cancers with an elevated BMI NEJM #obesity

Announcing the next dean of Johns Hopkins University Bloomberg School of Public Health, Keshia Pollack Porter! A champion for public health, Dr. Pollack Porter has distinguished herself as a leader in advancing policy change that promotes safe, healthy environments.

Stable OR teams contribute to better outcomes🤝✨ Each additional case done by same anesthesiologist-surgeon team 👉 ⬇️ major morbidity 🔓‼Opportunity is knocking: ⬆️outcomes by re-organizing teams How to do it? 🆕📝JAMA Surgery tinyurl.com/yx44pm96

#TechniquesThursday: Lung nodule detection by intraoperative ultrasound during robotic surgery. Read this brief research report from researchers at the University of Campania in #JTCVS Techniques: doi.org/10.1016/j.xjtc… Submit to #ITSOS2025: events.aats.org/international-…

🚨 BREAKING: HARMONi Trial Results Ivonescimab + chemo delivers a significant PFS benefit in EGFR-mutant NSCLC after EGFR TKI failure! 📊 PFS HR: 0.52 (p < 0.00001) 🧬 OS trending positive: HR 0.79 (p = 0.057)- not mature. 🌍 Global study with 38% Western pts 🛡 Manageable

Proud to share our study on population-level outcomes of EVLP in lung transplantation. Findings show EVLP doesn’t compromise 5YS and may reduce wait times 🏫Hopkins Surgery Johns Hopkins JSCOR encr.pw/Yekbt Grateful to collaborate with Errol L. Bush, MD, FACS Elliott R Haut, MD, PhD Betsy King, MD PhD

El tabaco mata 55 chilenos todos los días y el estado no recauda vía impuestos ni el 70% de lo que gasta en tratar problemas de salud asociados. GES para cesar tabaquismo anunciado ayer es una gran noticia para Chile y la salud pública.

🔥🚨OncoAlert Hot Off The Press Just presented ASCO #ASCO25 by the amazing Luis Paz-Ares ✅Results of #IMforte trial of: #Lurbinectedin + #Atezolizumab as 1st line #Maintenance Tx in #Patients with #ExtensiveStage #SmallCell #LungCancer. 👇🏻

~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! nejm.org/doi/full/10.10… #LCSM 1/

Fantastic talk on innovation in thoracic surgery and lung transplantation by ⁦Shaf Keshavjee⁩ 🫁 youtu.be/hqd9RKItVeA

Complex Esophageal Reconstruction for patients who need #esophagealReplacement as seen in the The Annals of Thoracic Surgery pubmed.ncbi.nlm.nih.gov/40274211/

Did you miss this #thoracic Global Grand Rounds webinar on new technologies for Lung Nodule Localization? Watch the recording on your time through the AATS Digital Resource Center. Hear panelists discuss intraoperative molecular and CT imaging: aats.org/resources/new-…

🎉 El martes 20 de mayo, el Instituto Nacional del Tórax protagonizó un avance sin precedentes en la medicina chilena al realizar con éxito el primer trasplante bipulmonar ex vivo dentro del sistema de salud público nacional. 👉 Mira el reportaje aquí 24horas.cl/actualidad/nac…

🎗️ 20 Years of Progress in Lung Adenocarcinoma New real-world data from France show a remarkable 📊 From 16.3% to 38.6% 3-year OS #Oncology #LungCancer #Immunotherapy #TargetedTherapy #RealWorldData #NEJM #KBPStudy #CancerResearch #Survival #Infographic NEJM

It’s an exciting time to be starting a career treating patients with lung cancer. Huge gains in two decades. Still, more can be done to improve quality & quantity of life w/ 🫁 cancer. 2000–>2020 Local dz 3 yr OS 49%—>79% Locally adv 3 yr OS 18%—>50% evidence.nejm.org/doi/full/10.10…

Check out this exciting new study led by Matthew Smeltzer Raymond Osarogiagbon, MBBS, FACP in JAMA Network Open!! Changing the USPSTF lung screening criteria from a 20-pack-year cutoff to a 20-year duration cutoff (Potter Criteria) greatly increases access to screening while maintaining screening